Potent and orally efficacious PROTAC degraders of estrogen receptor α (ER α )

被引：0
|
作者：
Rej, Rohan K.
Chen, Zhixiang
Acharyya, Ranjan K.
Wu, Dimin
Hu, Biao
Xu, Guozhang
Nagilla, Rakesh
Metwally, Hoda
Wang, Yu
Wen, Bo
Sun, Duxin
Bai, Longchuan
Wang, Shaomeng
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4510
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4510
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs)
    Li, Yuanyuan
    Zhang, Silong
    Zhang, Jing
    Hu, Zhiye
    Xiao, Yuan
    Huang, Jian
    Dong, Chune
    Huang, Shengtang
    Zhou, Hai-Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 172 : 48 - 61
  • [22] A computational study of potent series of selective estrogen receptor degraders for breast cancer therapy
    Zekri, Afaf
    Harkati, Dalal
    Kenouche, Samir
    Saleh, Basil A.
    Alnajjar, Radwan
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (20): : 11078 - 11100
  • [23] Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD)
    Dong, Jiaqiang
    Wang, Tie-lin
    Lu, Jianyu
    Ding, Charles Z.
    Hu, Lihong
    Hu, Guoping
    He, Huijun
    Zeng, Xu
    Li, Xiaoting
    Sun, Deheng
    Zhu, Yingjie
    Shen, Liang
    Gu, Qingyang
    Chan, Chi-chung
    Xia, Yuanfeng
    Li, Jian
    Chen, Shuhui
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (22)
  • [24] Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1
    Tavares, Francis X.
    Al-Barazanji, Kamal A.
    Bigham, Eric C.
    Bishop, Michael J.
    Britt, Christy S.
    Carlton, David L.
    Feldman, Paul L.
    Goetz, Aaron S.
    Grizzle, Mary K.
    Guo, Yu C.
    Handlon, Anthony L.
    Hertzog, Donald L.
    Ignar, Diane M.
    Lang, Daniel G.
    Ott, Ronda J.
    Peat, Andrew J.
    Zhou, Hui-Qiang
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) : 7095 - 7107
  • [25] The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening
    Lanter, James C.
    Fiordeliso, James J.
    Jiang, Weiqin
    Allan, George F.
    Lai, Muh-Tsann
    Linton, Olivia
    Hahn, Do Won
    Lundeen, Scott G.
    Sui, Zhihua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (01) : 123 - 126
  • [26] Design of orally bioavailable proteolysis targeting chimera (PROTAC) small-molecule degraders
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [27] Discovery of Potent, Highly Selective, and Efficacious SMARCA2 Degraders
    Li, Zhenwu
    Harikrishnan, Lalgudi S.
    Xu, Guozhang
    Samanta, Debangshu
    Clemente, Jose C.
    Leng, Lingying
    Tu, Wenbin
    Yang, Lin
    Huang, Liyue
    Wang, Mi
    Wang, Shaomeng
    Deng, Qiaolin
    Behshad, Elham
    Nagilla, Rakesh
    Orth, Peter
    Rice, Cory
    Strickland, Corey
    Mohammad, Helai P.
    Priestley, E. Scott
    Sui, Zhihua
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 68 (02) : 1134 - 1154
  • [28] Selective Estrogen Receptor Degraders (SERDs)
    Taylor, Melissa
    Kahn, Adriana
    Foldi, Julia
    CURRENT BREAST CANCER REPORTS, 2024, 16 (04) : 402 - 416
  • [29] Development of potent, highly selective and efficacious SMARCA2 degraders
    Yang, Lin
    Tu, Wenbin
    Huang, Liyue
    Leng, Lingying
    Jiang, Wei
    Wang, Meilin
    Wen, Bo
    Sun, Duxin
    Stuckey, Jeanne
    Wang, Shaomeng
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Discovery and evolution of orally bioavailable selective estrogen receptor degraders for ER plus breast cancer: From GDC-0810 to GDC-0927
    Kahraman, Mehmet
    Govek, Steven P.
    Nagasawa, Johnny Y.
    Lai, Andiliy
    Bonnefous, Celine
    Douglas, Karensa
    Sensintaffar, John
    Lu, Nhin
    Lee, KyoungJin
    Aparicio, Anna
    Kaufman, Josh
    Qian, Jing
    Shao, Gang
    Prudente, Rene
    Joseph, James D.
    Darimont, Beatrice
    Brigham, Daniel
    Heyman, Richard
    Rix, Peter J.
    Hager, Jeffrey H.
    Smith, Nicholas D.
    Blake, Robert A.
    Chang, Jae
    Choo, Edna
    Daemen, Anneleen
    Friedman, Lori S.
    Guan, Jane
    Hartman, Steven
    Ingalla, Ellen
    Kiefer, James R.
    Kleinheinz, Tracy
    Labadie, Sharada
    Metcalfe, Ciara
    Mody, Vidhi
    Nannini, Michelle
    Sampath, Deepak
    Young, Amy
    Vinogradova, Maia
    Zhou, Wei
    Liang, Jun
    Wang, Xiaojing
    CANCER RESEARCH, 2018, 78 (13)
12345